0001415889-13-000707.txt : 20130410
0001415889-13-000707.hdr.sgml : 20130410
20130410164615
ACCESSION NUMBER: 0001415889-13-000707
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130409
FILED AS OF DATE: 20130410
DATE AS OF CHANGE: 20130410
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ENRIGHT VINCENT D
CENTRAL INDEX KEY: 0001247208
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35218
FILM NUMBER: 13754104
MAIL ADDRESS:
STREET 1: ONE CORPORATE CENTER
CITY: RYE
STATE: NY
ZIP: 10580
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Echo Therapeutics, Inc.
CENTRAL INDEX KEY: 0001031927
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 411649949
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8 PENN CENTER
STREET 2: 1628 JFK BLVD, SUITE 300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
BUSINESS PHONE: 215-717-4100
MAIL ADDRESS:
STREET 1: 8 PENN CENTER
STREET 2: 1628 JFK BLVD, SUITE 300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
FORMER COMPANY:
FORMER CONFORMED NAME: SONTRA MEDICAL CORP
DATE OF NAME CHANGE: 20020702
FORMER COMPANY:
FORMER CONFORMED NAME: CHOICETEL COMMUNICATIONS INC/MN/
DATE OF NAME CHANGE: 20020701
FORMER COMPANY:
FORMER CONFORMED NAME: SONTRA MEDICAL CORP
DATE OF NAME CHANGE: 20020701
4
1
form4-04102013_080406.xml
X0306
4
2013-04-09
0001031927
Echo Therapeutics, Inc.
ECTE
0001247208
ENRIGHT VINCENT D
8 PENN CENTER
1628 JFK BLVD, SUITE 300
PHILADELPHIA
PA
19103
true
false
false
false
Common Stock
2013-04-09
4
A
0
4000
0
A
129000
D
The shares vest on April 9, 2014, provided, however that all unvested Restricted Shares shall immediately vest upon the sale of all or substantially all of the assets of the Company or all or substantially all of the outstanding capital stock of the Company in exchange for Liquid Proceeds. As used herein, "Liquid Proceeds" shall mean (a) cash; (b) securities which can be sold immediately on NYSE or NASDAQ; (c) securities which are or will be registered such that they can be sold upon on NYSE or NASDAQ upon termination of a lock-up period not to exceed one hundred eighty (180) days ; or (d) or a combination of cash and the foregoing securities
/s/ Kimberly A. Burke, Attorney-in-Fact
2013-04-10